DexTech Medical Overview

  • Founded
  • 2004

Founded
  • Status
  • Public

  • Employees
  • 1

Employees
  • Stock Symbol
  • DEX

Stock Symbol
  • Share Price
  • $0.47

  • (As of Friday Closing)

DexTech Medical General Information

Description

DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Stock Exchange
SAT
Primary Office
  • Box 389
  • 751 06 Uppsala
  • Sweden
+46 070-710 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DexTech Medical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.47 $0.47 $0.40 - $3.85 $8.74M 18.5M 9.4K -$0.03

DexTech Medical Financials Summary

In Thousands,
USD
TTM 31-Mar-2022 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 16,935 61,447 77,681 124,352
Revenue 0 0 0 0
EBITDA (213) (227) (217) (146)
Net Income (533) (708) (800) (913)
Total Assets 4,441 848 1,430 2,418
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

DexTech Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore DexTech Medical‘s full profile, request access.

Request a free trial

DexTech Medical Patents

DexTech Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2011516508-A Modified hydroxypolymer conjugates with bone accumulation and tumoricidal moieties Granted 07-Apr-2008 0000000000
EP-2274018-A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties Granted 07-Apr-2008 0000000000
CA-2719295-C Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties Active 07-Apr-2008 0000000000
CA-2719295-A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties Granted 07-Apr-2008 0000000000
US-20110118207-A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties Abandoned 07-Apr-2008 A61K51/065
To view DexTech Medical’s complete patent history, request access »

DexTech Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial